Who?
LEADERSHIP
EXPERIENCE
Principal and Founder
Bryan Allinson bring 20+ years of leadership in Health Artificial Intelligence and Machine Learning, Life Sciences, Medical Device, and Health Services. He helped grow businesses 100x, with over $100 million in sales. Navigate complex relationships to enable client success. Engage enterprise and product sales by engaging cross-functional teams, consulting with decision makers, overcoming obstacles and resistance. Focus on value, impact, strategy, technical, regulatory, and return on investment / financial. Lead healthcare partnerships for Deep 6 AI, including National Cancer Institute (NCI) and College of Surgeons (CoS) comprehensive cancer centers. Successful revenue generation for AdventHealth, Geisinger, University of Texas, UPMC. Startup founder roles include Lung Therapeutics, Cernostics.
Growth
$100M+
Lead go-to-market and enterprise sales strategies for Health AI/ML SaaS driving 100x growth and scale revenues to over $100 million by securing long-term contracts with leading health systems, providers, and life sciences clients.
Impact
50%
Over half of all biologic and small molecule therapeutics, medical devices, and health AI originated out of a health system, hospital, or university laboratory.
Our experts have substantial experience advancing health innovations derived from health organizations and academic medical centers. We help de-risk scientific, technical, manufacturing, clinical risks, providing marketable solutions to patients and providers.
Regulatory
FDA, CMS, HIPAA Regulatory and Compliance Experts
We help navigate compliance requirements to bring drugs, devices and software to market. Strategy, documentation, quality management, clinical trials, labeling.
